InterGard silver bifurcated graft: Features and results of a multicenter clinical study

Journal of Vascular Surgery

Volumn 44, Issue 2, 2006, Pages 339-346

  Ricco, Jean Baptiste ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CEFAMANDOLE; CEFAZOLIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLLAGEN; LOW MOLECULAR WEIGHT HEPARIN; POLYESTER; SILVER; VANCOMYCIN;

ADULT; AGED; AMPUTATION; ANTIBIOTIC PROPHYLAXIS; AORTA ANEURYSM; ARTICLE; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; BYPASS SURGERY; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; FEMALE; GRAFT INFECTION; GRAFT PATENCY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMPLANTATION; INFECTION RATE; INFECTION RESISTANCE; KAPLAN MEIER METHOD; LERICHE SYNDROME; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; THROMBECTOMY; THROMBOSIS; TIME SERIES ANALYSIS; VASCULAR SURGERY; WOUND INFECTION;

AGED; ANTIBIOTIC PROPHYLAXIS; AORTA; AORTIC ANEURYSM, ABDOMINAL; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CROSS INFECTION; DRUG DELIVERY SYSTEMS; FEMALE; FEMORAL ARTERY; HUMANS; ILIAC ARTERY; MALE; POLYESTERS; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; SILVER; SURGICAL WOUND INFECTION; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; VASCULAR PATENCY;

EID: 33746520709     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.03.046     Document Type: Article

References (44)

1. Gröschel D.H.M., and Strain B.A. Arterial graft infections from a microbiologist view. In: Calligaro K.D., and Veith F.J. (Eds). Management of infected arterial grafts (1994), Quality Medical Publishing Inc, St. Louis 3-15
2. Kaiser A.B., Clayson K.N., Mulherin J.L., Roach A.C., Allen T.R., Edwards W.H., et al. Antibiotic prophylaxis in vascular surgery. Ann Surg 188 (1978) 283-289
3. Pitt H.A., Postier R.G., MacGowan A.W., Franck L.W., Surmak A.J., Sitzman J.V., et al. Prophylactic antibiotics in vascular surgery. Topical, systemic, or both. Ann Surg 192 (1980) 356-364
4. Hasselgren P.O., Ivarsson L., Risberg B., and Seeman T. Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study. Ann Surg 200 (1984) 86-92
5. Bambauer R., Mestres P., Schiel R., Schneidewind J.H., Goudjinon R., Latza R., et al. Surface treated large bore catheters with silver based coatings versus untreated catheters for extracorporeal detoxification methods. ASAIO J 44 (1998) 303-308
6. Shah P.M., Modak S., Fox C.L., Babu S.C., Sampath L., Clauss R.H., et al. PTFE graft treated with silver norfloxacin. drug retention and resistance to bacterial challenge. J Surg Res 42 (1987) 298-303
7. Slawson R.M., Lee H., and Trevors J.T. Bacterial interactions with silver. Biol Met 3 (1990) 151-154
8. Hardman S., Cope A., Swann A., Bell P.R., Naylor A.R., and Hayes P.D. An in vitro model to compare the antimicrobial activity of silver-coated versus rifampicin-soaked vascular grafts. Ann Vasc Surg 18 (2004) 308-313
9. Feng Q.L., Wu J., Chen G.Q., Cui F.Z., Kim T.N., and Kim J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 15; (2000) 52 :662-8
10. Fung M.C., and Bowen D.L. Silver products for medical indications. risk-benefit Assessment. J Toxicol Clin 34 (1996) 119-126
11. McDonnell G., and Russell A.D. Antiseptics and disinfectants. activity, action, and resistance. Clin Microbiol Rev 12 (1999) 147-179
12. Benvenisty A.I., Tannenbaum G., Ahlborn T.N., Fox C.L., Modak S., Sampath L., et al. Control of prosthetic bacterial infection. evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft. J Surg Res 44 (1988) 1-7
13. Slawson R.M., Van Dyke M.I., Lee H., and Trevors J.T. Germanium and silver resistance, accumulation and toxicity in microorganisms. Plasmid 27 (1992) 72-79
14. Szilagyi D.E., Smith R.F., Elliott J.P., and Vrandecic M.P. Infection in arterial reconstruction with synthetic grafts. Ann Surg 176 (1972) 321-333
15. De Vries S.O., and Hunink M.G. Results of aortic bifurcation grafts for aortoiliac occlusive disease. a meta-analysis. J Vasc Surg 26 (1997) 558-569
16. Cormier J.M., Laurian C., Noel Y., Gigou F., Ricco J.B., and Fichelle J.M. Aorto-femoral bypass with polytetrafluoroethylene prostheses. preliminary results in 363 cases. Ann Vasc Surg 1 (1986) 43-49
17. Schneider J.R., Zwolak R.M., Walsh D.B., McDaniel M.D., and Cronenwett J.L. Lack of diameter effect on short-term patency of size-matched Dacron aortobifemoral grafts. J Vasc Surg 13 (1991) 785-790
18. Hallett J.W., Marshall D.M., Petterson T.M., Gray D.T., Bower T.C., Cherry Jr. K.J., et al. Graft-related complications after abdominal aortic aneurysm repair. population-based experience. J Vasc Surg 25 (1997) 277-284
19. Nevelsteen A., Wouters L., and Suy R. Aortofemoral Dacron reconstruction for aorto-iliac occlusive disease. a 25-year survey. Eur J Vasc Surg 5 (1991) 179-186
20. Goldstone J., and Moore W.S. Infection in vascular prostheses. clinical manifestations and surgical management. Am J Surg 128 (1974) 225-233
21. Bouhoutsos J., Chavatzas D., Martin P., and Morris T. Infected synthetic arterial grafts. Br J Surg 61 (1974) 108-111
22. Jamieson G.G., DeWeese J.A., and Rob C.G. Infected arterial grafts. Ann Surg 181 (1975) 850-852
23. Liekweg W.G., and Greenfield L.J. Vascular prosthetic infections. collected experience and results of treatment. Surgery 81 (1977) 335-342
24. Yashar J.J., Weyman A.K., Burnard R.J., and Yashar J. Survival and limb salvage in patients with infected arterial prostheses. Am J Surg 135 (1978) 499-504
25. Crawford E.S., Saleh S.A., and Babb III J.W. Infrarenal aortic aneurysm. factors influencing survival after operation performed over a 25-year period. Ann Surg 193 (1981) 699-709
26. Lorentzen J.E., Nielsen O.M., and Arendrup H. Vascular graft infection. An analysis of sixty-two grafts infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 98 (1985) 81-86
27. O'Hara J.P., Hertzer N.R., Beven E.G., and Krajewski L.P. Surgical management of infected abdominal aortic graft. A review of a 25-year experience. J Vasc Surg 3 (1986) 725-731
28. Szilagyi D.E., Elliott J.P., and Smith R.F. A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease. J Vasc Surg 3 (1986) 421-436
29. Edwards W.H., Martin R.S., and Jenkins J.M. Primary graft infections. J Vasc Surg 6 (1987) 235-239
30. Al-Khaffaf H., and Charlesworth D. Albumin-coated vascular protheses. A five-year follow-up. J Vasc Surg 23 (1996) 686-690
31. Prager M.R., Hoblaj T., Nanobashvili J., Sporn E., Polterauer P., Wagner O., et al. Collagen- versus gelatin-coated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease. long-term results of a prospective randomized multicenter trial. Surgery 134 (2003) 80-85
32. Antonios V.S., Noel A.A., Steckelberg J.M., Wilson W.R., Mandrekar J.N., Harmsen W.S., et al. Prosthetic vascular graft infection. a risk factor analysis using a case-control study. J Infect (2005). http://www.elsevierhealth.com/journals/jinf On line: www.elsevierhealth.com/journals/jinf
33. Bandyk D.F., and Back M.R. Infection in prosthetic vascular grafts. In: Rutherford R.B. (Ed). Vascular surgery. 6th ed. (2005), Elsevier Saunders, St Louis 875-894
34. Naylor A.R. Regarding "limitations in the use of rifampicin-gelatin grafts against virulent organisms.". J Vasc Surg 35 (2002) 823-824
35. Wright J.B., Lam K., and Burrell R.E. Wound management in an era of increasing bacterial antibiotic resistance. a role for topical silver treatment. Am J Infect Control 26 (1998) 572-577
36. Lelievre H., Lina G., Jones M.E., Olive C., Forey F., Roussel-Delvallez M., et al. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J Clin Microbiol 37 (1999) 3452-3457
37. Earnshaw J.J. The current role of rifampicin-impregnated grafts. pragmatism versus science. Eur J Vasc Endovasc Surg 20 (2000) 409-412
38. D'Addato M., Curti T., Freyrie A., and Italian Investigators Group. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft. 2-year follow-up of a prospective clinical trial. Cardiovasc Surg 4 (1996) 200-204
39. D'Addato M., Curti T., and Freyrie A. The rifampicin-bonded gelseal graft. Eur J Vasc Endovasc Surg 14 suppl A (1997) 15-17
40. Braithwaite B.D., Davies B., Heather B.P., Earnshaw J.J., and Joint Vascular Research Group. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Br J Surg 85 (1998) 1378-1381
41. Earnshaw J.J., Whitman B., and Heather B.P. Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic Dacron grafts. Br J Surg 87 (2000) 758-759
42. Zegelman M., and Günther G. Collagen-silver coated polyester grafts are the best "resistant to infections" synthetic grafts. Experience since 1999. In: Becquemin J.P., Loisance D., and Watelet J. (Eds). Controversies and update in vascular and cardiovascular surgery (2003), Edizioni Minerva Medica, Torino 35-40
43. Parry D.J., Waterworth A., Kessel D., Robertson I., Berridge D.C., and Scott D.J. Endovascular repair of an inflammatory abdominal aortic aneurysm complicated by aortoduodenal fistulation with an unusual presentation. J Vasc Surg 33 (2001) 874-879
44. Batt M., Magne J.L., Alric P., Muzj A., Ruotolo C., Ljungstrom K.G., et al. In situ revascularization with silver coated polyester grafts to treat aortic infection. early and midterm results. J Vasc Surg 38 (2003) 983-989